Pathology Faculty
Wahid T. Hanna, M.D.
Professor
Departments of Pathology, Medicine and Medical Genetics
Education
Ain-Shams University, Cairo, Egypt - M.B.B. Ch., 1969
Ain-Shams University Hospital
St. Catherine's Hospital, Birkenhead, England
Hematology, Liverpool University Hospital, Liverpool, England
Hematology/Oncology, University of Tennessee Memorial Research Center, Knoxville, TN
Certification
International Board of Clinical and Applied Thrombosis, Hemostasis and Vascular Medicine
Special Interests
Clinical Hematology
Appointments
Director, East Tennessee Comprehensive Hemophilia Center, The University of Tennessee Medical Center at Knoxville
Publications
Hanna WT, Bona RD, Zimmerman CE, Carta CA, Hebert GZ, Rickles FR The use of intermediate and high purity factor VIII products in the treatment of von Willebrand disease.Thromb Haemost. 1994 Feb;71(2):173-179
Mah MW, Royce RA, Rathouz PJ, Wang JG, White GC 2nd, Janco RL, Hanna WT, Davis PC, Johnson CA, Poon MC, et al. Prevalence of hepatitis A antibodies in hemophiliacs: preliminary results from the Southeastern Delta Hepatitis Study. Vox Sang 1994;67 Suppl 1:21-22.
Hanna WT, Rawson FL, Yates JD, Goldman MH, Zimmerman C, Painter PC 3d. von Willebrand's disease and arteriosclerosis. Am J Hematol 1993 Dec;44(4):289.
Iannuzzi MC, Hidaka N, Boehnke M, Bruck ME, Hanna WT, Collins FS, Ginsburg D. Analysis of the relationship of von Willebrand disease (vWD) and hereditary hemorrhagic telangiectasia and identification of a potential type IIA vWD mutation (IIe865 to Thr)..Am J Hum Genet 1991 Apr;48(4):757-763.
Send e-mail to Wahid T. Hanna, M.D.
|
